WinCap Financial’s Gilead Sciences GILD Stock Holding History

WinCap Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$740K	Buy	5,853 +134	+2%	+$17.7K	0.4%	59
2026 Q1	$797K	Buy	5,719 +212	+4%	+$29.7K	0.53%	52
2025 Q4	$676K	Buy	5,507 +99	+2%	+$12K	0.46%	56
2025 Q3	$600K	Buy	5,408 +209	+4%	+$23.8K	0.41%	60
2025 Q2	$576K	Sell	5,199 -1,083	-17%	-$115K	0.46%	59
2025 Q1	$704K	Buy	+6,282	New	+$648K	0.67%	50

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

WinCap Financial's GILD Position: Q2 2026 in Review

WinCap Financial increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $17.7K and bringing the position to 5,853 shares worth $740K. The position accounts for 0.4% of the portfolio, ranked #59.

WinCap Financial first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $797K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

WinCap Financial held 5,853 shares of Gilead Sciences worth $740K as of Q2 2026.
WinCap Financial bought 134 Gilead Sciences shares in Q2 2026, an estimated $17.7K.
Gilead Sciences made up 0.4% of WinCap Financial's portfolio in Q2 2026, its #59 holding.
WinCap Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
WinCap Financial's Gilead Sciences position peaked at $797K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WinCap Financial's 13F filing for Q2 2026, filed 9 Jul 2026.